Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000150:complications*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015140:Dementia, Vascular / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D005702:Galantamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D011569:Psychiatric Status Rating Scales; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D005702:Galantamine